Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
Early cancer detection through AI-analyzed blood tests could lead to personalized mRNA vaccine production in just 48 hours, according to Oracle CEO Larry Ellison.
Allergy & Immunology February 3rd 2025
Annals of Internal Medicine
Although genomic classifier tests for prostate cancer show promise, a systematic review of 22 studies reveals marked differences between observational and trial data in how these tests influence risk stratification and treatment selection.
Oncology, Medical February 3rd 2025
Oncology Learning Network
Fixed-duration venetoclax-based therapy demonstrates sustained efficacy in CLL, with 65.2% of first-line patients remaining treatment-free five years after completion.
Clinical Pharmacology February 3rd 2025
Parkinson’s News Today
Blood-based mitochondrial DNA testing could provide a less invasive alternative to spinal taps for Parkinson’s diagnosis, with implications for earlier intervention and treatment.
Allergy & Immunology January 22nd 2025
Mayo Clinic Labs
Poor metabolizers of UGT1A1 face a significantly increased risk of severe neutropenia from irinotecan therapy, making genetic testing crucial for appropriate dose modification.
Clinical Pharmacology December 3rd 2024
Hematology Advisor
The combination of ponatinib and blinatumomab demonstrated a 95% complete response rate and 91% 3-year overall survival rate in patients with Ph-positive ALL.
Hematology August 26th 2024
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS